 | • レポートコード：MRC2-11QY03345 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血漿のグローバル市場について調査・分析したレポートです。種類別（免疫グロブリン、アルブミン、プロテアーゼ阻害剤、凝固因子濃縮物、その他）市場規模、用途別（病院・診療所、研究所、学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血漿の競争状況、市場シェア ・世界の血漿市場：種類別市場規模 2015年-2020年（免疫グロブリン、アルブミン、プロテアーゼ阻害剤、凝固因子濃縮物、その他） ・世界の血漿市場：種類別市場規模予測 2021年-2026年（免疫グロブリン、アルブミン、プロテアーゼ阻害剤、凝固因子濃縮物、その他） ・世界の血漿市場：用途別市場規模 2015年-2020年（病院・診療所、研究所、学術機関） ・世界の血漿市場：用途別市場規模予測 2021年-2026年（病院・診療所、研究所、学術機関） ・北米の血漿市場分析：米国、カナダ ・ヨーロッパの血漿市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血漿市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血漿市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血漿市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter International、CSL、Grifols、Octapharma、ADMA Biologics、Cerus Corp、Sanquin、Shanghai Raas、TCS Biosciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Plasma is the liquid portion of the blood. Plasma is the versatile component and makes about 55% of the blood. Plasma is the composite mixture of more than 700 proteins and other substances which are vital for the efficient functioning of the human body. Plasma helps in regulating body temperature and blood pressure. It serves as a medium for exchange of proteins, nutrients and hormones to the different parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma. Plasma is extracted as proteins and substances and used as main ingredients in medical products to replace body fluids, clotting factors and antibodies. Plasma is used as a component for the treatment of serious health problems such as hemophilia and autoimmune disorders.
North America dominates the global market for blood plasma due to large number of aging population. Asia followed by the Europe is expected to show high growth rates in the next five years in global blood plasma market. China is expected to be the fastest growing blood plasma markets in Asia region. Some of the key driving forces for blood plasma market in emerging countries are large pool of patients and rising government funding.
Market Analysis and Insights: Global Blood Plasma Market
The global Blood Plasma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Blood Plasma Scope and Market Size
Blood Plasma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blood Plasma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Blood Plasma market is segmented into
Immunoglobulin
Albumin
Protease Inhibitors
Coagulation Factor Concentrates
Others
Segment by Application, the Blood Plasma market is segmented into
Hospitals and Clinics
Research Laboratories
Academic Institutions
Regional and Country-level Analysis
The Blood Plasma market is analysed and market size information is provided by regions (countries).
The key regions covered in the Blood Plasma market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Blood Plasma Market Share Analysis
Blood Plasma market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Blood Plasma business, the date to enter into the Blood Plasma market, Blood Plasma product introduction, recent developments, etc.
The major vendors covered:
Baxter International
CSL
Grifols
Octapharma
ADMA Biologics
Cerus Corp
Sanquin
Shanghai Raas
TCS Biosciences
1 Study Coverage
1.1 Blood Plasma Product Introduction
1.2 Market Segments
1.3 Key Blood Plasma Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Blood Plasma Market Size Growth Rate by Type
1.4.2 Immunoglobulin
1.4.3 Albumin
1.4.4 Protease Inhibitors
1.4.5 Coagulation Factor Concentrates
1.4.6 Others
1.5 Market by Application
1.5.1 Global Blood Plasma Market Size Growth Rate by Application
1.5.2 Hospitals and Clinics
1.5.3 Research Laboratories
1.5.4 Academic Institutions
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Blood Plasma Market Size, Estimates and Forecasts
2.1.1 Global Blood Plasma Revenue 2015-2026
2.1.2 Global Blood Plasma Sales 2015-2026
2.2 Global Blood Plasma, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Blood Plasma Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Blood Plasma Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Blood Plasma Competitor Landscape by Players
3.1 Blood Plasma Sales by Manufacturers
3.1.1 Blood Plasma Sales by Manufacturers (2015-2020)
3.1.2 Blood Plasma Sales Market Share by Manufacturers (2015-2020)
3.2 Blood Plasma Revenue by Manufacturers
3.2.1 Blood Plasma Revenue by Manufacturers (2015-2020)
3.2.2 Blood Plasma Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Blood Plasma Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Blood Plasma Revenue in 2019
3.2.5 Global Blood Plasma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Blood Plasma Price by Manufacturers
3.4 Blood Plasma Manufacturing Base Distribution, Product Types
3.4.1 Blood Plasma Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Blood Plasma Product Type
3.4.3 Date of International Manufacturers Enter into Blood Plasma Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Blood Plasma Market Size by Type (2015-2020)
4.1.1 Global Blood Plasma Sales by Type (2015-2020)
4.1.2 Global Blood Plasma Revenue by Type (2015-2020)
4.1.3 Blood Plasma Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Blood Plasma Market Size Forecast by Type (2021-2026)
4.2.1 Global Blood Plasma Sales Forecast by Type (2021-2026)
4.2.2 Global Blood Plasma Revenue Forecast by Type (2021-2026)
4.2.3 Blood Plasma Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Blood Plasma Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Blood Plasma Market Size by Application (2015-2020)
5.1.1 Global Blood Plasma Sales by Application (2015-2020)
5.1.2 Global Blood Plasma Revenue by Application (2015-2020)
5.1.3 Blood Plasma Price by Application (2015-2020)
5.2 Blood Plasma Market Size Forecast by Application (2021-2026)
5.2.1 Global Blood Plasma Sales Forecast by Application (2021-2026)
5.2.2 Global Blood Plasma Revenue Forecast by Application (2021-2026)
5.2.3 Global Blood Plasma Price Forecast by Application (2021-2026)
6 North America
6.1 North America Blood Plasma by Country
6.1.1 North America Blood Plasma Sales by Country
6.1.2 North America Blood Plasma Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Blood Plasma Market Facts & Figures by Type
6.3 North America Blood Plasma Market Facts & Figures by Application
7 Europe
7.1 Europe Blood Plasma by Country
7.1.1 Europe Blood Plasma Sales by Country
7.1.2 Europe Blood Plasma Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Blood Plasma Market Facts & Figures by Type
7.3 Europe Blood Plasma Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Blood Plasma by Region
8.1.1 Asia Pacific Blood Plasma Sales by Region
8.1.2 Asia Pacific Blood Plasma Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Blood Plasma Market Facts & Figures by Type
8.3 Asia Pacific Blood Plasma Market Facts & Figures by Application
9 Latin America
9.1 Latin America Blood Plasma by Country
9.1.1 Latin America Blood Plasma Sales by Country
9.1.2 Latin America Blood Plasma Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Blood Plasma Market Facts & Figures by Type
9.3 Central & South America Blood Plasma Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Blood Plasma by Country
10.1.1 Middle East and Africa Blood Plasma Sales by Country
10.1.2 Middle East and Africa Blood Plasma Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Blood Plasma Market Facts & Figures by Type
10.3 Middle East and Africa Blood Plasma Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Description and Business Overview
11.1.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Blood Plasma Products Offered
11.1.5 Baxter International Related Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description and Business Overview
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Blood Plasma Products Offered
11.2.5 CSL Related Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Description and Business Overview
11.3.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Grifols Blood Plasma Products Offered
11.3.5 Grifols Related Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Description and Business Overview
11.4.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Octapharma Blood Plasma Products Offered
11.4.5 Octapharma Related Developments
11.5 ADMA Biologics
11.5.1 ADMA Biologics Corporation Information
11.5.2 ADMA Biologics Description and Business Overview
11.5.3 ADMA Biologics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ADMA Biologics Blood Plasma Products Offered
11.5.5 ADMA Biologics Related Developments
11.6 Cerus Corp
11.6.1 Cerus Corp Corporation Information
11.6.2 Cerus Corp Description and Business Overview
11.6.3 Cerus Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Cerus Corp Blood Plasma Products Offered
11.6.5 Cerus Corp Related Developments
11.7 Sanquin
11.7.1 Sanquin Corporation Information
11.7.2 Sanquin Description and Business Overview
11.7.3 Sanquin Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanquin Blood Plasma Products Offered
11.7.5 Sanquin Related Developments
11.8 Shanghai Raas
11.8.1 Shanghai Raas Corporation Information
11.8.2 Shanghai Raas Description and Business Overview
11.8.3 Shanghai Raas Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Shanghai Raas Blood Plasma Products Offered
11.8.5 Shanghai Raas Related Developments
11.9 TCS Biosciences
11.9.1 TCS Biosciences Corporation Information
11.9.2 TCS Biosciences Description and Business Overview
11.9.3 TCS Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.9.4 TCS Biosciences Blood Plasma Products Offered
11.9.5 TCS Biosciences Related Developments
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Description and Business Overview
11.1.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Blood Plasma Products Offered
11.1.5 Baxter International Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Blood Plasma Market Estimates and Projections by Region
12.1.1 Global Blood Plasma Sales Forecast by Regions 2021-2026
12.1.2 Global Blood Plasma Revenue Forecast by Regions 2021-2026
12.2 North America Blood Plasma Market Size Forecast (2021-2026)
12.2.1 North America: Blood Plasma Sales Forecast (2021-2026)
12.2.2 North America: Blood Plasma Revenue Forecast (2021-2026)
12.2.3 North America: Blood Plasma Market Size Forecast by Country (2021-2026)
12.3 Europe Blood Plasma Market Size Forecast (2021-2026)
12.3.1 Europe: Blood Plasma Sales Forecast (2021-2026)
12.3.2 Europe: Blood Plasma Revenue Forecast (2021-2026)
12.3.3 Europe: Blood Plasma Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Blood Plasma Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Blood Plasma Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Blood Plasma Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Blood Plasma Market Size Forecast by Region (2021-2026)
12.5 Latin America Blood Plasma Market Size Forecast (2021-2026)
12.5.1 Latin America: Blood Plasma Sales Forecast (2021-2026)
12.5.2 Latin America: Blood Plasma Revenue Forecast (2021-2026)
12.5.3 Latin America: Blood Plasma Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Blood Plasma Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Blood Plasma Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Blood Plasma Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Blood Plasma Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Blood Plasma Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Blood Plasma Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Blood Plasma Market Segments
Table 2. Ranking of Global Top Blood Plasma Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Blood Plasma Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Immunoglobulin
Table 5. Major Manufacturers of Albumin
Table 6. Major Manufacturers of Protease Inhibitors
Table 7. Major Manufacturers of Coagulation Factor Concentrates
Table 8. Major Manufacturers of Others
Table 9. Global Blood Plasma Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Blood Plasma Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Blood Plasma Sales by Regions 2015-2020 (K MT)
Table 12. Global Blood Plasma Sales Market Share by Regions (2015-2020)
Table 13. Global Blood Plasma Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Blood Plasma Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Blood Plasma Sales Share by Manufacturers (2015-2020)
Table 16. Global Blood Plasma Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Blood Plasma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Plasma as of 2019)
Table 18. Blood Plasma Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Blood Plasma Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Blood Plasma Price (2015-2020) (USD/MT)
Table 21. Blood Plasma Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Blood Plasma Product Type
Table 23. Date of International Manufacturers Enter into Blood Plasma Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Plasma Sales by Type (2015-2020) (K MT)
Table 26. Global Blood Plasma Sales Share by Type (2015-2020)
Table 27. Global Blood Plasma Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Blood Plasma Revenue Share by Type (2015-2020)
Table 29. Blood Plasma Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Blood Plasma Sales by Application (2015-2020) (K MT)
Table 31. Global Blood Plasma Sales Share by Application (2015-2020)
Table 32. North America Blood Plasma Sales by Country (2015-2020) (K MT)
Table 33. North America Blood Plasma Sales Market Share by Country (2015-2020)
Table 34. North America Blood Plasma Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Blood Plasma Revenue Market Share by Country (2015-2020)
Table 36. North America Blood Plasma Sales by Type (2015-2020) (K MT)
Table 37. North America Blood Plasma Sales Market Share by Type (2015-2020)
Table 38. North America Blood Plasma Sales by Application (2015-2020) (K MT)
Table 39. North America Blood Plasma Sales Market Share by Application (2015-2020)
Table 40. Europe Blood Plasma Sales by Country (2015-2020) (K MT)
Table 41. Europe Blood Plasma Sales Market Share by Country (2015-2020)
Table 42. Europe Blood Plasma Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Blood Plasma Revenue Market Share by Country (2015-2020)
Table 44. Europe Blood Plasma Sales by Type (2015-2020) (K MT)
Table 45. Europe Blood Plasma Sales Market Share by Type (2015-2020)
Table 46. Europe Blood Plasma Sales by Application (2015-2020) (K MT)
Table 47. Europe Blood Plasma Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Blood Plasma Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific Blood Plasma Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Blood Plasma Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Blood Plasma Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Blood Plasma Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific Blood Plasma Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Blood Plasma Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific Blood Plasma Sales Market Share by Application (2015-2020)
Table 56. Latin America Blood Plasma Sales by Country (2015-2020) (K MT)
Table 57. Latin America Blood Plasma Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Blood Plasma Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Blood Plasma Revenue Market Share by Country (2015-2020)
Table 60. Latin America Blood Plasma Sales by Type (2015-2020) (K MT)
Table 61. Latin America Blood Plasma Sales Market Share by Type (2015-2020)
Table 62. Latin America Blood Plasma Sales by Application (2015-2020) (K MT)
Table 63. Latin America Blood Plasma Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Blood Plasma Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa Blood Plasma Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Blood Plasma Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Blood Plasma Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Blood Plasma Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa Blood Plasma Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Blood Plasma Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa Blood Plasma Sales Market Share by Application (2015-2020)
Table 72. Baxter International Corporation Information
Table 73. Baxter International Description and Major Businesses
Table 74. Baxter International Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Baxter International Product
Table 76. Baxter International Recent Development
Table 77. CSL Corporation Information
Table 78. CSL Description and Major Businesses
Table 79. CSL Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. CSL Product
Table 81. CSL Recent Development
Table 82. Grifols Corporation Information
Table 83. Grifols Description and Major Businesses
Table 84. Grifols Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Grifols Product
Table 86. Grifols Recent Development
Table 87. Octapharma Corporation Information
Table 88. Octapharma Description and Major Businesses
Table 89. Octapharma Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Octapharma Product
Table 91. Octapharma Recent Development
Table 92. ADMA Biologics Corporation Information
Table 93. ADMA Biologics Description and Major Businesses
Table 94. ADMA Biologics Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. ADMA Biologics Product
Table 96. ADMA Biologics Recent Development
Table 97. Cerus Corp Corporation Information
Table 98. Cerus Corp Description and Major Businesses
Table 99. Cerus Corp Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Cerus Corp Product
Table 101. Cerus Corp Recent Development
Table 102. Sanquin Corporation Information
Table 103. Sanquin Description and Major Businesses
Table 104. Sanquin Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Sanquin Product
Table 106. Sanquin Recent Development
Table 107. Shanghai Raas Corporation Information
Table 108. Shanghai Raas Description and Major Businesses
Table 109. Shanghai Raas Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Shanghai Raas Product
Table 111. Shanghai Raas Recent Development
Table 112. TCS Biosciences Corporation Information
Table 113. TCS Biosciences Description and Major Businesses
Table 114. TCS Biosciences Blood Plasma Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. TCS Biosciences Product
Table 116. TCS Biosciences Recent Development
Table 117. Global Blood Plasma Sales Forecast by Regions (2021-2026) (K MT)
Table 118. Global Blood Plasma Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Blood Plasma Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Blood Plasma Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Blood Plasma Sales Forecast by Country (2021-2026) (K MT)
Table 122. North America: Blood Plasma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Blood Plasma Sales Forecast by Country (2021-2026) (K MT)
Table 124. Europe: Blood Plasma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Blood Plasma Sales Forecast by Region (2021-2026) (K MT)
Table 126. Asia Pacific: Blood Plasma Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Blood Plasma Sales Forecast by Country (2021-2026) (K MT)
Table 128. Latin America: Blood Plasma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Blood Plasma Sales Forecast by Country (2021-2026) (K MT)
Table 130. Middle East and Africa: Blood Plasma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Blood Plasma Players
Table 135. Blood Plasma Customers List
Table 136. Blood Plasma Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Plasma Product Picture
Figure 2. Global Blood Plasma Sales Market Share by Type in 2020 & 2026
Figure 3. Immunoglobulin Product Picture
Figure 4. Albumin Product Picture
Figure 5. Protease Inhibitors Product Picture
Figure 6. Coagulation Factor Concentrates Product Picture
Figure 7. Others Product Picture
Figure 8. Global Blood Plasma Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals and Clinics
Figure 10. Research Laboratories
Figure 11. Academic Institutions
Figure 12. Blood Plasma Report Years Considered
Figure 13. Global Blood Plasma Market Size 2015-2026 (US$ Million)
Figure 14. Global Blood Plasma Sales 2015-2026 (K MT)
Figure 15. Global Blood Plasma Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Blood Plasma Sales Market Share by Region (2015-2020)
Figure 17. Global Blood Plasma Sales Market Share by Region in 2019
Figure 18. Global Blood Plasma Revenue Market Share by Region (2015-2020)
Figure 19. Global Blood Plasma Revenue Market Share by Region in 2019
Figure 20. Global Blood Plasma Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Blood Plasma Revenue in 2019
Figure 22. Blood Plasma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Blood Plasma Sales Market Share by Type (2015-2020)
Figure 24. Global Blood Plasma Sales Market Share by Type in 2019
Figure 25. Global Blood Plasma Revenue Market Share by Type (2015-2020)
Figure 26. Global Blood Plasma Revenue Market Share by Type in 2019
Figure 27. Global Blood Plasma Market Share by Price Range (2015-2020)
Figure 28. Global Blood Plasma Sales Market Share by Application (2015-2020)
Figure 29. Global Blood Plasma Sales Market Share by Application in 2019
Figure 30. Global Blood Plasma Revenue Market Share by Application (2015-2020)
Figure 31. Global Blood Plasma Revenue Market Share by Application in 2019
Figure 32. North America Blood Plasma Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Blood Plasma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Blood Plasma Sales Market Share by Country in 2019
Figure 35. North America Blood Plasma Revenue Market Share by Country in 2019
Figure 36. U.S. Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Blood Plasma Market Share by Type in 2019
Figure 41. North America Blood Plasma Market Share by Application in 2019
Figure 42. Europe Blood Plasma Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Blood Plasma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Blood Plasma Sales Market Share by Country in 2019
Figure 45. Europe Blood Plasma Revenue Market Share by Country in 2019
Figure 46. Germany Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Blood Plasma Market Share by Type in 2019
Figure 57. Europe Blood Plasma Market Share by Application in 2019
Figure 58. Asia Pacific Blood Plasma Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Blood Plasma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Blood Plasma Sales Market Share by Region in 2019
Figure 61. Asia Pacific Blood Plasma Revenue Market Share by Region in 2019
Figure 62. China Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Blood Plasma Market Share by Type in 2019
Figure 85. Asia Pacific Blood Plasma Market Share by Application in 2019
Figure 86. Latin America Blood Plasma Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Blood Plasma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Blood Plasma Sales Market Share by Country in 2019
Figure 89. Latin America Blood Plasma Revenue Market Share by Country in 2019
Figure 90. Mexico Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Blood Plasma Market Share by Type in 2019
Figure 97. Latin America Blood Plasma Market Share by Application in 2019
Figure 98. Middle East and Africa Blood Plasma Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Blood Plasma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Blood Plasma Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Blood Plasma Revenue Market Share by Country in 2019
Figure 102. Turkey Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Blood Plasma Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Blood Plasma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Blood Plasma Market Share by Type in 2019
Figure 109. Middle East and Africa Blood Plasma Market Share by Application in 2019
Figure 110. North America Blood Plasma Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Blood Plasma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Blood Plasma Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Blood Plasma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Blood Plasma Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Blood Plasma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Blood Plasma Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Blood Plasma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Blood Plasma Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Blood Plasma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
血液バンク・血漿冷凍庫の世界市場（～2026年） A Blood Bank & Plasma Freezer stores biomedical supplies like blood products at controlled temperatures. For safety, the system includes monitoring equipment to regularly check and report temperatures. It may also have security measures like locking doors to protect the integrity of the contents. Bl…- 血漿分画の世界市場（～2026年） Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation. Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the…
- 血小板・血漿の世界市場（～2026年） Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cell…
- 血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
- 血漿成分分離器の世界市場（～2026年） Plasma are generally used to increase blood volume or it can be separated into individual plasma proteins such as fibrinogen, factor VIII, anti-thrombin III and factor IX. Improving healthcare infrastructure is expected to boost the growth of the plasma component separator market. Market Analysis an…